Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Deepti Telaraja
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
George Washington University
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
George Washington University
ORCID:
0009-0004-0515-8189
Observed ORCID:
0009-0004-0515-8189
OpenAlex ID:
A5026416398
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
2023
·
Deepti Telaraja
, Yvette L. Kasamon
, et al.
·
Clinical Cancer Research
·
48
PDF
Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles
2023
·
Elizabeth E. Sweeney
, Palak Sekhri
, et al.
·
Cytotherapy
·
10
PDF
Approvals in 2022: overall survival, dose optimization, new approvals and beyond
2023
·
Deepti Telaraja
, Nicole Gormley
, et al.
·
Nature Reviews Clinical Oncology
·
2
Show more works
View as search
Works count:
3
Citation count:
60
H-index:
2
I10-index:
2
Year
Topic
Type